Get more information on Synthetic Biology Market - Request Free Sample Report
The Synthetic Biology Market Size was valued at USD 14.19 Billion in 2023, and is expected to reach USD 65.61 Billion by 2032, and grow at a CAGR of 19.61% over the forecast period 2024-2032.
Increase in Research & Development Activities across Various Domains to Drive Global Market. The global market is prophesied to make progress on the back of increasing research and development conducted across several sectors. Players are turning to applying synthetic biology solutions to (very) aid conventional biofuel production, and more the performance of these processes and utilizing low-cost inputs e.g. waste materials better Biotechnology is being used to develop sustainable materials for example, high fashion brands such as Modern Meadow and Bolt Threads, Vitro Labs etc. Strong investments by private & public partnerships. According to SynBioBeta, startup investment in the synthetic biology sector amounted to USD 7.8 billion in 2020 and as much as another USD 18.0 billion in 2021. Arbor Biotechnologies and DNA Script brought in about USD 215 million and USD 167.2 million, respectively. This huge investment is improving market liquidity and thus enabling companies of all links in the supply chain to grow.
Second, genome editing is developing and bio-foundries are being established globally that form one of the most promising strengths for synthetic biology to emerge as a global strength in an arena to construct a new bio-based economy via utilization of genbanks - natural resources present on earth along with huge markets. It also examines the possible impediments, including inadequate infrastructure and policies to support the long-term growth of the field as well as suggests ways coming out across through public-private partnership; more effective multilateral cooperation; a governance framework, etc. Moreover, the markets are optimizing with the new technologies to address demand scale which also opens a path of current inflows emerging from untapped regions. For example, in November 2021 an article about Creative Biogene's broad shRNA products to aid RNAi research. As mentioned above, the company provides shRNA clones and siRNA libraries with extensive expertise and experience in this field to help advance RNAi research by providing quality products that are effective, convenient, and dependable.
KEY DRIVERS:
Advances In Gene Editing Technologies Such As CRISPR/Cas9 and Synthetic Genomics Have Revolutionized the Field, Making It Possible to Design and Construct New Biological Parts and Systems with Greater Precision.
There is Growing Interest in Synthetic Biology for Developing New Therapies, Vaccines, And Diagnostic Tools, Particularly in Personalized Medicine and Regenerative Medicine.
RESTRAINTS:
The Lack of Standardized Regulations and Guidelines Across Different Countries Can Complicate the Approval and Commercialization Processes for Synthetic Biology Products.
The Development of Synthetic Biology Products Often Requires Significant Investment in Research, Development, And Clinical Trials, Which Can Be a Barrier for Smaller Companies and Startups.
OPPORTUNITY:
Synthetic Biology Holds the Promise of Developing New Vaccines, Treatments, And Diagnostic Tools, Particularly for Diseases That Are Currently Difficult to Address with Conventional Methods.
Opportunities Exist in Creating New Biological Systems and Organisms for Various Applications, Including Agriculture, Healthcare, And Industrial Biotechnology.
By Technology
PCR segment dominated the market with a value of 28% in 2023 and is expected to sustain throughout the forecast period as well Polymerase Chain Reaction (PCR) is now a prevalent method used for the detection and analysis of gene sequences. Because its real-time PCR assays are highly sensitive and specific, it is the predominant technology in many applications of genomic studies utilizing PCR. This method has many applications for example in forensic analysis, DNA cloning, and molecular diagnostics. In contrast, the demand for genome editing technology is expected to grow at a significant CAGR in the future. The forecasted increase in the use of gene-editing tools may destination a few benefits relating to artificial and genetically modified organisms as driving supplementation. Gene editing techniques have enhanced the capacity to develop proprietary goods with advantageous properties in multiple industries such as human & animal health care, and agriculture.
By Product
Oligonucleotide/Oligo Pools and Synthetic DNA segment had a market share of 32% in the year 2023. Oligonucleotides are often the point of origin in many molecular and synthetic biology applications. This method is increasingly adopted in targeted NGS, mutagenesis experiments, DNA computing, and majorly for the CRISPR gene editing segments. For example, OligoMix is a novel and customizable genomics solution. It uses multiple sequences of oligonucleotide in vast parallel. It is less than 0.8 cents per base for the same. Whereas the enzymes segment is likely to grow at 19.35% CAGR during the forecast period. Enzymes act as catalysts in biochemical reactions. The potential use of enzymatic synthesis to introduce longer genes in a time-effective manner will drive the growth. This technology, however, is still in the development phase and not yet commercialized.
By Application
Healthcare was the largest vertical segment in 2023 holding 55% in 2023. Synthetic biology-based diagnostics provide rapid, real-time, and non-invasive detection of infectious agents, cancer cells, and therapeutics in a very specific or sensitive manner. They describe rational engineering strategies for novel dynamic bio-sensing systems, which consist of a processor embedded with a sensor and reporter. By indication, the segment is driven by a rise in cases of diseases like multiple sclerosis. For example, synthetic biologists at the University of Toronto Engineering are working on personalized stem cells from patient tissues to cure diseases in July 2022. These research initiatives are expected to bolster the growth of this segment.
Get Customized Report as per your Business Requirement - Request For Customized Report
North America held the largest share of 42% in the year 2023. This dominant share is due to higher private sector investments, supportive regulation, and government help. The U.S. mainly focuses on research in proteomics, drug screening & discovery, and genomics structure prediction leading to the growth of the synthetic biology market. The Asia Pacific is expected to be the fastest-growing region of this market, majorly due to developments in Asian countries with rising investments and growing partnerships & funding that are driving growth for synthetic biology products. The efforts of many Asian countries to establish national institutes, state-sponsored research programs, and academia-industry collaborations for technological innovation toward synthetic biology will likely contribute further momentum.
The leading players in the market are focusing on strategies to drive profit including partnerships, mergers & acquisitions, geographical expansions, and strategic collaborations. One such instance occurred in July 2021, Codexis Inc. & Kalsec Inc. confirmed the expansion of their research collaboration and entrance into a unique supply agreement for a novel enzyme to be used in the manufacturing process of finding natural hop acid developed by Kalsec's enabling IPA product lines. The key market players include Synthetic Genomics Inc., Euro fins Scientific, Thermo Fisher Scientific, Inc., Illumina, Inc., Creative Biogene, Merck Kgaa (Sigma-Aldrich Co. Llc), Novozymes, Synthetic Genomics Inc., Codexis, Inc., Enbiotix, Inc. & other players.
In January 2024, The US-based Rice University founded the Rice Synthetic Biology Institute, with a vision to catalyze collaborative research in synthetic biology for translation into technologies that can serve society.
In May 2023, GenScript Biotech Corporation (sponsor of the SynBioBeta Conference) presented their newest synthetic biology tool and techniques with strategic partner Allozymes alongside a select line-up of KOLs.
|
Report Attributes |
Details |
|
Market Size in 2023 |
US$ 14.19 Billion |
|
Market Size by 2032 |
US$ 65.61 Billion |
|
CAGR |
CAGR of 19.61% From 2024 to 2032 |
|
Base Year |
2023 |
|
Forecast Period |
2024-2032 |
|
Historical Data |
2020-2022 |
|
Report Scope & Coverage |
Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
|
Key Segments |
•By Product (Oligonucleotide/Oligo Pools and Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-Nucleic Acids & Chassis Organism), |
|
Regional Analysis/Coverage |
North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
|
Company Profiles |
Creative Biogene, Thermo Fisher Scientific, Inc., Illumina, Inc., Euro fins Scientific, Novozymes, Merck Kgaa (Sigma-Aldrich Co. Llc), Synthetic Genomics Inc., Codexis, Inc., Synthetic Genomics Inc., Enbiotix, Inc. & other players |
|
Key Drivers |
•Advances In Gene Editing Technologies Such As CRISPR/Cas9 and Synthetic Genomics Have Revolutionized the Field, Making It Possible to Design and Construct New Biological Parts and Systems with Greater Precision. |
|
RESTRAINTS |
•The Lack of Standardized Regulations and Guidelines Across Different Countries Can Complicate the Approval and Commercialization Processes for Synthetic Biology Products. |
Ans: The synthetic biology Market is expected to grow at 19.61% CAGR from 2024 to 2032.
Ans: According to our analysis, the synthetic biology market is anticipated to reach USD 65.61 billion by 2032.
Ans: Increasing funding for research and development.
Ans. North America will lead a global synthetic biology market.
Ans: Yes, you may request customization based on your company's needs.
TABLE OF CONTENTS
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Industry Flowchart
3. Research Methodology
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
5. Porter’s 5 Forces Model
6. Pest Analysis
7. Synthetic Biology Market Segmentation, By Product
7.1 Introduction
7.2 Oligonucleotide/Oligo Pools and Synthetic DNA
7.3 Enzymes
7.4 Cloning Technologies Kits
7.5 Xeno-Nucleic Acids
7.6 Chassis Organism
8. Synthetic Biology Market Segmentation, By Technology
8.1 Introduction
8.2 NGS Technology
8.3 PCR Technology
8.4 Genome Editing Technology
8.5 Bioprocessing Technology
8.6 Others
9. Synthetic Biology Market Segmentation, By Application
9.1 Introduction
9.2 Healthcare
9.2.1 Clinical
9.2.2 Non-Clinical
9.3 Non-healthcare
9.3.1 Biotech Crops
9.3.2 Specialty Chemicals
9.3.3 Bio-fuels
9.3.4 Others
10. Synthetic Biology Market Segmentation, By End-Use
10.1 Introduction
10.2 Biotechnology and Pharmaceutical Companies
10.3 Academic and Government Research Institutes
10.4 Others
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 Trend Analysis
11.2.2 North America Synthetic Biology Market by Country
11.2.3 North America Synthetic Biology Market By Product
11.2.4 North America Synthetic Biology Market By Technology
11.2.5 North America Synthetic Biology Market By Application
11.2.6 North America Synthetic Biology Market By End-Use
11.2.7 USA
11.2.7.1 USA Synthetic Biology Market By Product
11.2.7.2 USA Synthetic Biology Market By Technology
11.2.7.3 USA Synthetic Biology Market By Application
11.2.7.4 USA Synthetic Biology Market By End-Use
11.2.8 Canada
11.2.8.1 Canada Synthetic Biology Market By Product
11.2.8.2 Canada Synthetic Biology Market By Technology
11.2.8.3 Canada Synthetic Biology Market By Application
11.2.8.4 Canada Synthetic Biology Market By End-Use
11.2.9 Mexico
11.2.9.1 Mexico Synthetic Biology Market By Product
11.2.9.2 Mexico Synthetic Biology Market By Technology
11.2.9.3 Mexico Synthetic Biology Market By Application
11.2.9.4 Mexico Synthetic Biology Market By End-Use
11.3 Europe
11.3.1 Trend Analysis
11.3.2 Eastern Europe
11.3.2.1 Eastern Europe Synthetic Biology Market by Country
11.3.2.2 Eastern Europe Synthetic Biology Market By Product
11.3.2.3 Eastern Europe Synthetic Biology Market By Technology
11.3.2.4 Eastern Europe Synthetic Biology Market By Application
11.3.2.5 Eastern Europe Synthetic Biology Market By End-Use
11.3.2.6 Poland
11.3.2.6.1 Poland Synthetic Biology Market By Product
11.3.2.6.2 Poland Synthetic Biology Market By Technology
11.3.2.6.3 Poland Synthetic Biology Market By Application
11.3.2.6.4 Poland Synthetic Biology Market By End-Use
11.3.2.7 Romania
11.3.2.7.1 Romania Synthetic Biology Market By Product
11.3.2.7.2 Romania Synthetic Biology Market By Technology
11.3.2.7.3 Romania Synthetic Biology Market By Application
11.3.2.7.4 Romania Synthetic Biology Market By End-Use
11.3.2.8 Hungary
11.3.2.8.1 Hungary Synthetic Biology Market By Product
11.3.2.8.2 Hungary Synthetic Biology Market By Technology
11.3.2.8.3 Hungary Synthetic Biology Market By Application
11.3.2.8.4 Hungary Synthetic Biology Market By End-Use
11.3.2.9 Turkey
11.3.2.9.1 Turkey Synthetic Biology Market By Product
11.3.2.9.2 Turkey Synthetic Biology Market By Technology
11.3.2.9.3 Turkey Synthetic Biology Market By Application
11.3.2.9.4 Turkey Synthetic Biology Market By End-Use
11.3.2.10 Rest of Eastern Europe
11.3.2.10.1 Rest of Eastern Europe Synthetic Biology Market By Product
11.3.2.10.2 Rest of Eastern Europe Synthetic Biology Market By Technology
11.3.2.10.3 Rest of Eastern Europe Synthetic Biology Market By Application
11.3.2.10.4 Rest of Eastern Europe Synthetic Biology Market By End-Use
11.3.3 Western Europe
11.3.3.1 Western Europe Synthetic Biology Market by Country
11.3.3.2 Western Europe Synthetic Biology Market By Product
11.3.3.3 Western Europe Synthetic Biology Market By Technology
11.3.3.4 Western Europe Synthetic Biology Market By Application
11.3.3.5 Western Europe Synthetic Biology Market By End-Use
11.3.3.6 Germany
11.3.3.6.1 Germany Synthetic Biology Market By Product
11.3.3.6.2 Germany Synthetic Biology Market By Technology
11.3.3.6.3 Germany Synthetic Biology Market By Application
11.3.3.6.4 Germany Synthetic Biology Market By End-Use
11.3.3.7 France
11.3.3.7.1 France Synthetic Biology Market By Product
11.3.3.7.2 France Synthetic Biology Market By Technology
11.3.3.7.3 France Synthetic Biology Market By Application
11.3.3.7.4 France Synthetic Biology Market By End-Use
11.3.3.8 UK
11.3.3.8.1 UK Synthetic Biology Market By Product
11.3.3.8.2 UK Synthetic Biology Market By Technology
11.3.3.8.3 UK Synthetic Biology Market By Application
11.3.3.8.4 UK Synthetic Biology Market By End-Use
11.3.3.9 Italy
11.3.3.9.1 Italy Synthetic Biology Market By Product
11.3.3.9.2 Italy Synthetic Biology Market By Technology
11.3.3.9.3 Italy Synthetic Biology Market By Application
11.3.3.9.4 Italy Synthetic Biology Market By End-Use
11.3.3.10 Spain
11.3.3.10.1 Spain Synthetic Biology Market By Product
11.3.3.10.2 Spain Synthetic Biology Market By Technology
11.3.3.10.3 Spain Synthetic Biology Market By Application
11.3.3.10.4 Spain Synthetic Biology Market By End-Use
11.3.3.11 Netherlands
11.3.3.11.1 Netherlands Synthetic Biology Market By Product
11.3.3.11.2 Netherlands Synthetic Biology Market By Technology
11.3.3.11.3 Netherlands Synthetic Biology Market By Application
11.3.3.11.4 Netherlands Synthetic Biology Market By End-Use
11.3.3.12 Switzerland
11.3.3.12.1 Switzerland Synthetic Biology Market By Product
11.3.3.12.2 Switzerland Synthetic Biology Market By Technology
11.3.3.12.3 Switzerland Synthetic Biology Market By Application
11.3.3.12.4 Switzerland Synthetic Biology Market By End-Use
11.3.3.13 Austria
11.3.3.13.1 Austria Synthetic Biology Market By Product
11.3.3.13.2 Austria Synthetic Biology Market By Technology
11.3.3.13.3 Austria Synthetic Biology Market By Application
11.3.3.13.4 Austria Synthetic Biology Market By End-Use
11.3.3.14 Rest of Western Europe
11.3.3.14.1 Rest of Western Europe Synthetic Biology Market By Product
11.3.3.14.2 Rest of Western Europe Synthetic Biology Market By Technology
11.3.3.14.3 Rest of Western Europe Synthetic Biology Market By Application
11.3.3.14.4 Rest of Western Europe Synthetic Biology Market By End-Use
11.4 Asia-Pacific
11.4.1 Trend Analysis
11.4.2 Asia-Pacific Synthetic Biology Market by Country
11.4.3 Asia-Pacific Synthetic Biology Market By Product
11.4.4 Asia-Pacific Synthetic Biology Market By Technology
11.4.5 Asia-Pacific Synthetic Biology Market By Application
11.4.6 Asia-Pacific Synthetic Biology Market By End-Use
11.4.7 China
11.4.7.1 China Synthetic Biology Market By Product
11.4.7.2 China Synthetic Biology Market By Technology
11.4.7.3 China Synthetic Biology Market By Application
11.4.7.4 China Synthetic Biology Market By End-Use
11.4.8 India
11.4.8.1 India Synthetic Biology Market By Product
11.4.8.2 India Synthetic Biology Market By Technology
11.4.8.3 India Synthetic Biology Market By Application
11.4.8.4 India Synthetic Biology Market By End-Use
11.4.9 Japan
11.4.9.1 Japan Synthetic Biology Market By Product
11.4.9.2 Japan Synthetic Biology Market By Technology
11.4.9.3 Japan Synthetic Biology Market By Application
11.4.9.4 Japan Synthetic Biology Market By End-Use
11.4.10 South Korea
11.4.10.1 South Korea Synthetic Biology Market By Product
11.4.10.2 South Korea Synthetic Biology Market By Technology
11.4.10.3 South Korea Synthetic Biology Market By Application
11.4.10.4 South Korea Synthetic Biology Market By End-Use
11.4.11 Vietnam
11.4.11.1 Vietnam Synthetic Biology Market By Product
11.4.11.2 Vietnam Synthetic Biology Market By Technology
11.4.11.3 Vietnam Synthetic Biology Market By Application
11.4.11.4 Vietnam Synthetic Biology Market By End-Use
11.4.12 Singapore
11.4.12.1 Singapore Synthetic Biology Market By Product
11.4.12.2 Singapore Synthetic Biology Market By Technology
11.4.12.3 Singapore Synthetic Biology Market By Application
11.4.12.4 Singapore Synthetic Biology Market By End-Use
11.4.13 Australia
11.4.13.1 Australia Synthetic Biology Market By Product
11.4.13.2 Australia Synthetic Biology Market By Technology
11.4.13.3 Australia Synthetic Biology Market By Application
11.4.13.4 Australia Synthetic Biology Market By End-Use
11.4.14 Rest of Asia-Pacific
11.4.14.1 Rest of Asia-Pacific Synthetic Biology Market By Product
11.4.14.2 Rest of Asia-Pacific Synthetic Biology Market By Technology
11.4.14.3 Rest of Asia-Pacific Synthetic Biology Market By Application
11.4.14.4 Rest of Asia-Pacific Synthetic Biology Market By End-Use
11.5 Middle East & Africa
11.5.1 Trend Analysis
11.5.2 Middle East
11.5.2.1 Middle East Synthetic Biology Market by Country
11.5.2.2 Middle East Synthetic Biology Market By Product
11.5.2.3 Middle East Synthetic Biology Market By Technology
11.5.2.4 Middle East Synthetic Biology Market By Application
11.5.2.5 Middle East Synthetic Biology Market By End-Use
11.5.2.6 UAE
11.5.2.6.1 UAE Synthetic Biology Market By Product
11.5.2.6.2 UAE Synthetic Biology Market By Technology
11.5.2.6.3 UAE Synthetic Biology Market By Application
11.5.2.6.4 UAE Synthetic Biology Market By End-Use
11.5.2.7 Egypt
11.5.2.7.1 Egypt Synthetic Biology Market By Product
11.5.2.7.2 Egypt Synthetic Biology Market By Technology
11.5.2.7.3 Egypt Synthetic Biology Market By Application
11.5.2.7.4 Egypt Synthetic Biology Market By End-Use
11.5.2.8 Saudi Arabia
11.5.2.8.1 Saudi Arabia Synthetic Biology Market By Product
11.5.2.8.2 Saudi Arabia Synthetic Biology Market By Technology
11.5.2.8.3 Saudi Arabia Synthetic Biology Market By Application
11.5.2.8.4 Saudi Arabia Synthetic Biology Market By End-Use
11.5.2.9 Qatar
11.5.2.9.1 Qatar Synthetic Biology Market By Product
11.5.2.9.2 Qatar Synthetic Biology Market By Technology
11.5.2.9.3 Qatar Synthetic Biology Market By Application
11.5.2.9.4 Qatar Synthetic Biology Market By End-Use
11.5.2.10 Rest of Middle East
11.5.2.10.1 Rest of Middle East Synthetic Biology Market By Product
11.5.2.10.2 Rest of Middle East Synthetic Biology Market By Technology
11.5.2.10.3 Rest of Middle East Synthetic Biology Market By Application
11.5.2.10.4 Rest of Middle East Synthetic Biology Market By End-Use
11.5.3 Africa
11.5.3.1 Africa Synthetic Biology Market by Country
11.5.3.2 Africa Synthetic Biology Market By Product
11.5.3.3 Africa Synthetic Biology Market By Technology
11.5.3.4 Africa Synthetic Biology Market By Application
11.5.3.5 Africa Synthetic Biology Market By End-Use
11.5.3.6 Nigeria
11.5.3.6.1 Nigeria Synthetic Biology Market By Product
11.5.3.6.2 Nigeria Synthetic Biology Market By Technology
11.5.3.6.3 Nigeria Synthetic Biology Market By Application
11.5.3.6.4 Nigeria Synthetic Biology Market By End-Use
11.5.3.7 South Africa
11.5.3.7.1 South Africa Synthetic Biology Market By Product
11.5.3.7.2 South Africa Synthetic Biology Market By Technology
11.5.3.7.3 South Africa Synthetic Biology Market By Application
11.5.3.7.4 South Africa Synthetic Biology Market By End-Use
11.5.3.8 Rest of Africa
11.5.3.8.1 Rest of Africa Synthetic Biology Market By Product
11.5.3.8.2 Rest of Africa Synthetic Biology Market By Technology
11.5.3.8.3 Rest of Africa Synthetic Biology Market By Application
11.5.3.8.4 Rest of Africa Synthetic Biology Market By End-Use
11.6 Latin America
11.6.1 Trend Analysis
11.6.2 Latin America Synthetic Biology Market by Country
11.6.3 Latin America Synthetic Biology Market By Product
11.6.4 Latin America Synthetic Biology Market By Technology
11.6.5 Latin America Synthetic Biology Market By Application
11.6.6 Latin America Synthetic Biology Market By End-Use
11.6.7 Brazil
11.6.7.1 Brazil Synthetic Biology Market By Product
11.6.7.2 Brazil Synthetic Biology Market By Technology
11.6.7.3 Brazil Synthetic Biology Market By Application
11.6.7.4 Brazil Synthetic Biology Market By End-Use
11.6.8 Argentina
11.6.8.1 Argentina Synthetic Biology Market By Product
11.6.8.2 Argentina Synthetic Biology Market By Technology
11.6.8.3 Argentina Synthetic Biology Market By Application
11.6.8.4 Argentina Synthetic Biology Market By End-Use
11.6.9 Colombia
11.6.9.1 Colombia Synthetic Biology Market By Product
11.6.9.2 Colombia Synthetic Biology Market By Technology
11.6.9.3 Colombia Synthetic Biology Market By Application
11.6.9.4 Colombia Synthetic Biology Market By End-Use
11.6.10 Rest of Latin America
11.6.10.1 Rest of Latin America Synthetic Biology Market By Product
11.6.10.2 Rest of Latin America Synthetic Biology Market By Technology
11.6.10.3 Rest of Latin America Synthetic Biology Market By Application
11.6.10.4 Rest of Latin America Synthetic Biology Market By End-Use
12. Company Profiles
12.1 Creative Biogene
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Products/ Services Offered
12.1.4 The SNS View
12.2 Thermo Fisher Scientific, Inc.
12.2.1 Company Overview
12.2.2 Financial
12.2.3 Products/ Services Offered
12.2.4 The SNS View
12.3 Illumina, Inc.
12.3.1 Company Overview
12.3.2 Financial
12.3.3 Products/ Services Offered
12.3.4 The SNS View
12.4 Euro fins Scientific
12.4.1 Company Overview
12.4.2 Financial
12.4.3 Products/ Services Offered
12.4.4 The SNS View
12.5 Novozymes
12.5.1 Company Overview
12.5.2 Financial
12.5.3 Products/ Services Offered
12.5.4 The SNS View
12.6 Merck Kgaa (Sigma-Aldrich Co. Llc)
12.6.1 Company Overview
12.6.2 Financial
12.6.3 Products/ Services Offered
12.6.4 The SNS View
12.7 Synthetic Genomics Inc.
12.7.1 Company Overview
12.7.2 Financial
12.7.3 Products/ Services Offered
12.7.4 The SNS View
12.8 Codexis, Inc.
12.8.1 Company Overview
12.8.2 Financial
12.8.3 Products/ Services Offered
12.8.4 The SNS View
12.9 Synthetic Genomics Inc.
12.9.1 Company Overview
12.9.2 Financial
12.9.3 Products/ Services Offered
12.9.4 The SNS View
12.10 Enbiotix, Inc.
12.10.1 Company Overview
12.10.2 Financial
12.10.3 Products/ Services Offered
12.10.4 The SNS View
13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share Analysis
13.3 Recent Developments
13.3.1 Industry News
13.3.2 Company News
13.3.3 Mergers & Acquisitions
14. Use Case and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Technology
NGS Technology
PCR Technology
Genome Editing Technology
Bioprocessing Technology
Others
By Product
Oligonucleotide/Oligo Pools and Synthetic DNA
Enzymes
Cloning Technologies Kits
Xeno-Nucleic Acids
Chassis Organism
By Application
Healthcare
Clinical
Non-Clinical
Non-healthcare
Biotech Crops
Specialty Chemicals
Bio-fuels
Others
By End-Use
Biotechnology and Pharmaceutical companies
Academic and Government Research Institutes
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Hyperphosphatemia Treatment Market Size was valued at USD 1.33 billion in 2023, and is expected to reach USD 2.73 billion by 2032, and grow at a CAGR of 8.3% over the forecast period 2024-2032.
The Smart Hospitality Market is anticipated to increase at a CAGR of 30% from 2024 to 2032, from a value of USD 17.55 billion in 2023 and expected to reach USD 186.10 billion by 2032.
The Anesthesia Drugs Market Size was valued at USD 5.9 billion in 2023 & is expected to reach USD 8.6 billion by 2032 with a growing CAGR of 4.2% over the forecast period of 2024-2032.
The Biopreservation Market size was estimated at USD 2.82 billion in 2023 and is expected to reach USD 9.6 billion by 2032 at a CAGR of 28.4% during the forecast period of 2024-2032.
The Gas Chromatography Market Size was valued at USD 3.48 billion in 2023 and is expected to reach USD 5.47 billion by 2032 and grow at a CAGR of 5.16% over the forecast period 2024-2032.
The Injectable Cytotoxic Drugs Market size was USD 19.58 Billion in 2023 and is expected to Reach USD 38.15 Billion by 2032 and grow at a CAGR of 6.9% over the forecast period of 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
